Clinical Trials Update: Dec. 14, 2007
Generalized Anxiety Disorder (GAD) Contraception Shingles
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
Generalized Anxiety Disorder (GAD)
If you are aged 18 to 65, have generalized anxiety disorder, and haven't fully responded to escitalopram (Lexapro), paroxetine (Paxil), duloxetine (Cymbalta), or venlafaxine (Effexor XR), you may be eligible to participate in this study.
The research site is in Sherman Oaks, Calif.
If you are a woman aged 18 to 35 who is sexually active and is seeking contraception, you may qualify for this study.
The research site is in San Diego, Calif.
If you are aged 18 to 80 and have been diagnosed with post-herpetic neuralgia -- including pain for more than 6 months after healing of herpes zoster rash -- you may be eligible for this study.
The research site is in Hattiesburg, Miss.
Copyright 2007 Thomson CenterWatch. All rights reserved.